A novel type-2 innate lymphoid cell-based immunotherapy for cancer

A novel type-2 innate lymphoid cell-based immunotherapy for cancer

Cell-based cancer immunotherapy has achieved significant advancements, providing a source of hope for cancer patients. Notwithstanding the considerable progress in cell-based immunotherapy, the persistently low response rates and the exorbitant costs associated with their implementation still presen...

Full description

Bibliographic Details
Main Authors: Iryna Saranchova, Clara Wenjing Xia, Stephanie Besoiu, Pablo L. Finkel, Samantha L. S. Ellis, Suresh Kari, Lonna Munro, Cheryl G. Pfeifer, Ladan Fazli, Martin E. Gleave, Wilfred A. Jefferies
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Immunology
Subjects:
cell-based cancer immunotherapy
type 2 innate lymphoid cells
ILC2
interleukin-33
adoptive cell transfer
tumor infiltrating lymphocytes
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1317522/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1317522/full

Similar Items